Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease

Chronic beryllium disease (CBD) is a debilitating pulmonary disorder that occurs due to persistent exposure to beryllium (Be) particles in the workplace. Be-exposure causes activation of the innate immune system, resulting in the secretion of interleukins and chemokines that drive the accumulation o...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph M. Gaballa, Caley Valdez, Douglas G. Mack, Faiz Minhajuddin, Masoom Raza, Tabrez A. Mohammad, Allison K. Martin, Andrew Getahun, Charles A. Dinarello, Andrew P. Fontenot, Shaikh M. Atif
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1479348/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583762453463040
author Joseph M. Gaballa
Caley Valdez
Douglas G. Mack
Faiz Minhajuddin
Masoom Raza
Tabrez A. Mohammad
Allison K. Martin
Andrew Getahun
Charles A. Dinarello
Andrew P. Fontenot
Shaikh M. Atif
author_facet Joseph M. Gaballa
Caley Valdez
Douglas G. Mack
Faiz Minhajuddin
Masoom Raza
Tabrez A. Mohammad
Allison K. Martin
Andrew Getahun
Charles A. Dinarello
Andrew P. Fontenot
Shaikh M. Atif
author_sort Joseph M. Gaballa
collection DOAJ
description Chronic beryllium disease (CBD) is a debilitating pulmonary disorder that occurs due to persistent exposure to beryllium (Be) particles in the workplace. Be-exposure causes activation of the innate immune system, resulting in the secretion of interleukins and chemokines that drive the accumulation of B and T cells in the lungs. However, the mechanisms by which innate molecules influence the recruitment of B cells and B cell-mediated protection in CBD are poorly understood. In this study, we employed multiple approaches to examine the role of innate immune signaling and CD4+ T cells in B cell recruitment and function in the lungs. We show that the absence or blocking of IL-1R1 signaling prevents the recruitment of B cells to the lungs of BeO-exposed mice. Additionally, we show that B cell recruitment to the lungs depends on the chemokine receptor, CXCR5, and CD4+ T cells. In BeO-exposed mice, lung B cells down-regulate IgM but showed an increased IgD and CD44 surface expression. Further, RNA sequencing of pulmonary tissue-specific B cells in CBD revealed distinct gene signatures compared to splenic B cells, with increased expression of pathways involved in antigen presentation, tight junction interactions, and interferon signaling. Overall, our study shows that B cell recruitment and aggregate formation during CBD depend on sequential activation of innate and adaptive immune responses.
format Article
id doaj-art-0ac43f8d74484d6f83b67ac2bb288b72
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-0ac43f8d74484d6f83b67ac2bb288b722025-01-28T05:10:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011610.3389/fimmu.2025.14793481479348Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium diseaseJoseph M. Gaballa0Caley Valdez1Douglas G. Mack2Faiz Minhajuddin3Masoom Raza4Tabrez A. Mohammad5Allison K. Martin6Andrew Getahun7Charles A. Dinarello8Andrew P. Fontenot9Shaikh M. Atif10Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesGreehey Children's Cancer Research Institute, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesChronic beryllium disease (CBD) is a debilitating pulmonary disorder that occurs due to persistent exposure to beryllium (Be) particles in the workplace. Be-exposure causes activation of the innate immune system, resulting in the secretion of interleukins and chemokines that drive the accumulation of B and T cells in the lungs. However, the mechanisms by which innate molecules influence the recruitment of B cells and B cell-mediated protection in CBD are poorly understood. In this study, we employed multiple approaches to examine the role of innate immune signaling and CD4+ T cells in B cell recruitment and function in the lungs. We show that the absence or blocking of IL-1R1 signaling prevents the recruitment of B cells to the lungs of BeO-exposed mice. Additionally, we show that B cell recruitment to the lungs depends on the chemokine receptor, CXCR5, and CD4+ T cells. In BeO-exposed mice, lung B cells down-regulate IgM but showed an increased IgD and CD44 surface expression. Further, RNA sequencing of pulmonary tissue-specific B cells in CBD revealed distinct gene signatures compared to splenic B cells, with increased expression of pathways involved in antigen presentation, tight junction interactions, and interferon signaling. Overall, our study shows that B cell recruitment and aggregate formation during CBD depend on sequential activation of innate and adaptive immune responses.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1479348/fullinterleukinsIL-1IL-1RaAnakinrachemokinesinflammation
spellingShingle Joseph M. Gaballa
Caley Valdez
Douglas G. Mack
Faiz Minhajuddin
Masoom Raza
Tabrez A. Mohammad
Allison K. Martin
Andrew Getahun
Charles A. Dinarello
Andrew P. Fontenot
Shaikh M. Atif
Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease
Frontiers in Immunology
interleukins
IL-1
IL-1Ra
Anakinra
chemokines
inflammation
title Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease
title_full Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease
title_fullStr Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease
title_full_unstemmed Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease
title_short Interleukin-1 signaling and CD4+ T cells control B cell recruitment to the lungs in chronic beryllium disease
title_sort interleukin 1 signaling and cd4 t cells control b cell recruitment to the lungs in chronic beryllium disease
topic interleukins
IL-1
IL-1Ra
Anakinra
chemokines
inflammation
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1479348/full
work_keys_str_mv AT josephmgaballa interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT caleyvaldez interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT douglasgmack interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT faizminhajuddin interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT masoomraza interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT tabrezamohammad interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT allisonkmartin interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT andrewgetahun interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT charlesadinarello interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT andrewpfontenot interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease
AT shaikhmatif interleukin1signalingandcd4tcellscontrolbcellrecruitmenttothelungsinchronicberylliumdisease